Introduction
Back pain due to Lumbar Disc Disease is a major clinical problem. The treatment options range from physiotherapy to fusion surgery. Several minimally invasive procedures have also been developed in the recent past for its management. Disc-FX® is a new minimally invasive technique that combines percutaneous discectomy, nuclear ablation and annular modification.
Methods
We studied 22 consecutive patients who underwent Disc-FX for lumbar disc pathology non-responsive to non-operative treatment for at least 6 months. Based on MRI, these patients fell into 2 groups -11 with degenerative disc disease (DDD) and 11 with a contained lumbar disc herniation (CLDH). They were evaluated using Visual analogue scale (VAS), Oswestry Disability Index (ODI) and Short Form-36 (SF-36) scores preand postoperatively.
Results
Overall rate of re-intervention for persistent symptoms was 18.18% (4/22) -all in CLDH subgroup (4/11, 36.36%). At 6 months, mean pre-op VAS improved from 6.1 (2-8) to 3.42 (0-7), ODI reduced to 28.21 (2-68.9) from 37.64 (2-71.1) and SF-36 improved from 35.57 (24.1-56.8) pre-op to 40.463 (24.1-56.8) . 9 (42.85%) patients (4 with CLDH, 4 with DDD and 1 with both) said that they were not satisfied with the treatment and would not recommend it. 8 (38.09%) patients (5 with DDD, 2 with CLDH and 1 with both) who had partial to complete pain relief were satisfied and would recommend the procedure. 4 (19.04%) patients (1 with DDD and
